Plasma Levels of IL-6 in Patients With Untreated Major Depressive Disorder: Comparison With Catecholamine Metabolites

Neuropsychiatric Disease and Treatment
doi 10.2147/ndt.s195379
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Increase in IL-6 Levels Among Major Depressive Disorder Patients After a 6-Week Treatment With Duloxetine 60 Mg/Day: A Preliminary Observation

Neuropsychiatric Disease and Treatment
PsychiatryMental HealthBiological Psychiatry
2011English

Plasma Complement Component 4 Increases in Patients With Major Depressive Disorder

Neuropsychiatric Disease and Treatment
2017English

Dental Patients With Major Depressive Disorder

Current Oral Health Reports
2014English

Dream Contents in Patients With Major Depressive Disorder

Canadian Journal of Psychiatry
PsychiatryMental Health
2004English

Hypothyroidism in Patients With Asthma and Major Depressive Disorder

The Primary Care Companion to The Journal of Clinical Psychiatry
2007English

Trial of SAGE-217 in Patients With Major Depressive Disorder

New England Journal of Medicine
Medicine
2019English

Acetyl-L-Carnitine Deficiency in Patients With Major Depressive Disorder

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2018English

Impaired Social Decision Making in Patients With Major Depressive Disorder

BMC Psychiatry
PsychiatryMental Health
2014English

Duloxetine-Induced Liver Injury in Patients With Major Depressive Disorder

Psychiatry Investigation
PsychiatryMental HealthBiological Psychiatry
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy